The obesity medicine field has gained a new entrant, with AbbVie on Monday announcing it had licensed an experimental weight loss drug from a Danish company that is in a Phase 1 trial
10 nmol each of HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and PIPES (piperazine-N, N-bis(2-ethanesulfonic acid)) were added to each sample to serve as standards
Have Researched Berberine Specifically: If you've read research on berberine and are specifically interested in trying this compound but prefer transdermal delivery over oral supplements, NuraPatch offers that option
First developed for hypertension, patients in clinical trials for Viagra kept reporting that something interesting was happening when they took the drug
This group regained 14% of the weight, while those who remained on the drug continued to lose up to 5.5% more in the following weeks
Bioequivalence was established between the 100 mg tablet and both suspension strengths when administered as a single 200 mg dose